XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 28,217 $ (68,445) $ 97,330
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Loss from discontinued operations, net of tax     273
Depreciation and amortization 178,946 193,138 188,084
Long-lived and other asset impairment 21,397 79,556 44,663
Goodwill impairment   99,830  
Inventory write-downs 997 1,349 944
Amortization of operating lease ROU assets 3,880 3,477 2,931
Amortization of deferred financing costs 10,127 5,554 6,211
Amortization of debt discount   187 910
Amortization of debt premium (2,006) (84)  
Amortization of dedesignated interest rate swap 863    
Debt extinguishment loss   3,971 3,653
Interest rate swaps 3,539 3,178 (1,071)
Stock-based compensation expense 11,336 10,551 8,105
Non-cash restructuring charges   1,660  
Provision for credit losses (90) 3,525 2,567
(Gain) loss on sale of assets, net (11,313) 1,832 (16,016)
Gain on sale of business (18,945) (12,475)  
Deferred income tax provision (benefit) 10,379 (17,764) (39,597)
Amortization of contract costs 19,990 26,629 23,330
Deferred revenue recognized in earnings (10,382) (19,489) (42,268)
Change in assets and liabilities, net of acquisition:      
Accounts receivable, trade 4,445 36,395 3,248
Inventory (12,989) 3,972 6,036
Other assets 635 (5,797) 4,458
Contract costs, net (16,991) (13,262) (27,237)
Accounts payable and other liabilities 5,269 (15,089) (12,728)
Deferred revenue 10,217 12,732 36,578
Other (121) 147 12
Net cash provided by continuing operations 237,400 335,278 290,416
Net cash used in discontinued operations     (269)
Net cash provided by operating activities 237,400 335,278 290,147
Cash flows from investing activities:      
Capital expenditures (97,885) (140,302) (385,198)
Proceeds from sale of business 83,345 33,651  
Proceeds from sale of property, plant and equipment and other assets 29,562 18,911 80,961
Proceeds from insurance and other settlements 1,085 2,709 3,696
Cash paid in Elite Acquisition     (214,019)
Net cash provided by (used in) investing activities 16,107 (85,031) (514,560)
Cash flows from financing activities:      
Borrowings of long-term debt 704,751 1,049,000 2,395,250
Repayments of long-term debt (863,251) (1,204,375) (2,071,750)
Payments for debt issuance costs (2,451) (5,269) (22,426)
Proceeds from (payments for) settlement of interest rate swaps that include financing elements (4,390) (2,916) 1,180
Dividends paid to stockholders (89,343) (88,832) (78,530)
Net proceeds from issuance of common stock 3,401    
Proceeds from stock issued under ESPP 713 683 771
Purchases of treasury stock (2,465) (1,804) (2,007)
Contribution from Exterran Corporation   678  
Net cash provided by (used in) financing activities (253,035) (252,835) 222,488
Net increase (decrease) in cash and cash equivalents 472 (2,588) (1,925)
Cash and cash equivalents, beginning of period 1,097 3,685 5,610
Cash and cash equivalents, end of period 1,569 1,097 3,685
Supplemental disclosure of cash flow information:      
Interest paid (100,002) (99,797) (97,451)
Income taxes refunded (paid), net (247) (94) 1,973
Supplemental disclosure of non-cash investing and financing transactions:      
Accrued capital expenditures $ 7,641 1,624 11,767
Non-cash consideration received in July 2020 Disposition   $ 5,762  
Issuance of Archrock common stock pursuant to Elite Acquisition, net of tax     $ 225,880